Transplantation and Cellular Therapy | 2021
A qualitative analysis of state Medicaid coverage benefits for allogeneic hematopoietic cell transplantation (alloHCT) for patients with sickle cell disease (SCD).
Mupfudze TG, Preussler JM, Sees JA, SanCartier M, Arnold SD, Devine S
PubMed
PMID: 33836889
Abstract
Related Articles
CIBMTR Study #: HSR18-10